Amir Fathi, MD

Amir Fathi, MD, is a clinician investigator at the Mass General Research Institute and associate physician in Hematology and Medical Oncology at Massachusetts General Hospital. He also serves as an associate professor of medicine at Harvard Medical School. Dr. Fathi leads multiple clinical trials through the Dana-Farber/Harvard Cancer Center, with a research focus on developing and translating novel therapies for acute leukemias, including AML and APL. His areas of interest include FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates.